BDBM485867 US10947196, Compound 03-3

SMILES CC(C)(C)NC[C@H](O)c1cccc(n1)C(F)(F)F

InChI Key InChIKey=XBRCTDNTNIAHLP-VIFPVBQESA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 485867   

TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Curasen Therapeutics

US Patent
LigandPNGBDBM485867(US10947196, Compound 03-3)
Affinity DataEC50: <10nMAssay Description:Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Curasen Therapeutics

US Patent
LigandPNGBDBM485867(US10947196, Compound 03-3)
Affinity DataEC50:  55nMAssay Description:Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent